Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and Cash Equivalents $ 1,115,174 $ 555,967
Marketable Securities 4,505,825 11,003,071
Prepaid Expenses 1,371,407 1,106,347
Total Current Assets 6,992,406 12,665,385
Non-Current Assets    
Operating Lease Right-of-Use Assets 170,226 149,009
Goodwill 10,498,539 10,498,539
Investment in Oravax, Inc. 1,500,000 1,500,000
Total Non-Current Assets 12,168,765 12,147,548
Total Assets 19,161,171 24,812,933
Current Liabilities    
Trade and Other Payables 2,841,535 986,626
Operating Lease Liability 61,519 53,240
Total Current Liabilities 2,903,054 1,039,866
Non-Current Liabilities    
Due to MyMD Florida Shareholders 29,982 29,982
Operating Lease Liability, net of current portion 109,792 95,911
Total Non-Current Liabilities 139,774 125,893
Total Liabilities 3,042,828 1,165,759
Commitments and Contingencies  
SHAREHOLDERS’ EQUITY    
Series D Convertible Preferred Stock, 211,353 shares designated, no par value and a stated value of $0.01 per share, 72,992 shares issued and outstanding as of June 30, 2022 and December 31, 2021 144,524 144,524
Common stock, no par value, 500,000,000 shares authorized 38,058,245 and 37,673,110 issued and outstanding as of June 30, 2022 and December 31, 2021 102,293,464 102,064,218
Accumulated Deficit (86,319,645) (78,561,568)
Total Shareholders’ Equity 16,118,343 23,647,174
Total Liabilities and Shareholders’ Equity $ 19,161,171 $ 24,812,933